Agilent Technologies, Inc. $A Stock Position Lifted by New York State Common Retirement Fund

New York State Common Retirement Fund raised its stake in Agilent Technologies, Inc. (NYSE:A) by 1.5% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 288,447 shares of the medical research company’s stock after purchasing an additional 4,327 shares during the quarter. New York State Common Retirement Fund’s holdings in Agilent Technologies were worth $37,022,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Resona Asset Management Co. Ltd. lifted its stake in shares of Agilent Technologies by 6.2% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after purchasing an additional 5,767 shares during the last quarter. CCLA Investment Management raised its holdings in Agilent Technologies by 10.5% during the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after buying an additional 97,312 shares in the last quarter. TrueMark Investments LLC acquired a new stake in shares of Agilent Technologies in the second quarter worth about $1,999,000. Nuance Investments LLC boosted its stake in shares of Agilent Technologies by 13.5% during the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares in the last quarter. Finally, Osaic Holdings Inc. boosted its stake in shares of Agilent Technologies by 35.5% during the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock worth $8,017,000 after acquiring an additional 17,817 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Insider Transactions at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the transaction, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This trade represents a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 16,401 shares of company stock worth $2,468,962. 0.26% of the stock is owned by company insiders.

Agilent Technologies Trading Up 0.4%

Shares of Agilent Technologies stock opened at $133.84 on Friday. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The company’s fifty day simple moving average is $142.22 and its 200-day simple moving average is $134.39. The company has a market cap of $37.94 billion, a price-to-earnings ratio of 29.29, a PEG ratio of 3.87 and a beta of 1.29. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th were given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend was Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Rothschild & Co Redburn began coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective on the stock. TD Cowen lifted their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Bank of America upped their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Finally, Evercore ISI upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average target price of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.